Singulair (montelukast) is a proven bronchodilator that may aid people who are suffering from acute and chronic asthma. It also prevents exercise-induced bronchoconstriction. The medication may be prescribed in various forms of dispensers including oral capsules, inhaler, and tablets. Singulair has been approved for sale in the United States since 2003 by Merck & Co., Inc.